Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
In $285M deal, Novo taps Ascendis to help create monthly GLP-1
Novo Nordisk has signed a $285 million biobucks deal with Ascendis to help the Wegovy manufacturer reduce GLP-1 dosing frequency.
James Waldron
Nov 4, 2024 8:43am
AbbVie pays $65M for options on EvolveImmune's T-cell engagers
Oct 31, 2024 10:00am
GSK aims to extend lupus dominance via $300M T-cell engager deal
Oct 29, 2024 8:00am
AZ licenses discarded rare disease drug to Monopar Therapeutics
Oct 24, 2024 2:54pm
Roche bets up to $1B to expand Dyno gene therapy delivery pact
Oct 24, 2024 10:40am
Editas prioritizes in vivo therapies, seeks reni-cel partner
Oct 22, 2024 9:39am
